HCA vs LH
HCA Healthcare, Inc. and Labcorp Holdings Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | HCA | LH |
|---|---|---|
| Revenue | $75.6B | $14.0B |
| Net income | $6.8B | $876.5M |
| Gross margin | — | 28.8% |
| Net margin | 9.0% | 6.3% |
| Return on equity | 134.4% | 10.5% |
| Diluted EPS | $28.33 | $10.46 |
| Dividend / share | $2.88 | $2.88 |
| Payout ratio | 10.0% | 27.5% |
| Free cash flow | $7.7B | $1.2B |
| Equity | $-6.0B | $8.6B |
| Net debt / equity | 51.07× | 0.59× |
| Current ratio | 0.97× | 1.42× |
| Revenue CAGR 5y | 8.0% | −0.0% |
| Profit CAGR 5y | 12.6% | −10.8% |
HCA bills 5.4× the revenue of LH, and keeps more of each dollar of revenue as profit (9.0% against 6.3%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | HCA | LH |
|---|---|---|
| FY2025 | $75.6B | $14.0B |
| FY2024 | $70.6B | $13.0B |
| FY2023 | $65.0B | $12.2B |
| FY2022 | $60.2B | $11.9B |
| FY2021 | $58.8B | $13.1B |
| FY2020 | $51.5B | $14.0B |
| FY2019 | $51.3B | $11.6B |
| FY2018 | $46.7B | $11.3B |
| FY2017 | $43.6B | $10.3B |
| FY2016 | $41.5B | $9.6B |
Net income by year
Bottom line
| Fiscal year | HCA | LH |
|---|---|---|
| FY2025 | $6.8B | $876.5M |
| FY2024 | $5.8B | $746.0M |
| FY2023 | $5.2B | $418.0M |
| FY2022 | $5.6B | $1.3B |
| FY2021 | $7.0B | $2.4B |
| FY2020 | $3.8B | $1.6B |
| FY2019 | $3.5B | $823.8M |
| FY2018 | $3.8B | $883.7M |
| FY2017 | $2.2B | $1.2B |
| FY2016 | $2.9B | $711.8M |
Advertisement
AdSense · Rectangle 336×280